Genetic Testing, von Hippel Lindau , VHL, treatment, guideline, renal, carcinoma
Genetic Testing for VHL: Alberta Cancer Board Treatment Guidelines
Genetic Testing for von Hippel Lindau (VHL) Carriers in Patients with Renal Cell Carcinoma
 Open this treatment guideline (PDF)
Developed: December 2007 Revised: June 2009
Goals/Objectives
- To facilitate earlier detection of von Hippel Lindau (VHL) syndrome in patients presenting with renal cell carcinoma.
- To provide opportunities for improved treatment outcomes for patients with renal cell carcinoma caused by VHL syndrome.
- To identify the presence or absence of the VHL gene in symptomatic and asymptomatic affected individuals among at-risk family members.
- To identify the presence or absence of the VHL gene in symptomatic and asymptomatic affected individuals among at-risk family members.
|
|
 Can't find the information you need?
Tell us, and we'll help.
|
|
|
|